Feature | SCAI | May 14, 2018

SCAI 2018 Late-breaking Clinical Trials

Richard Schatz, M.D., (center) is research director of cardiovascular interventions at the Heart, Lung, and Vascular Center at Scripps Clinic, speaking at a SCAI session on collaboration with industry to bring new device technologies to market. He is best known as the co-inventor of the first coronary stent, the Palmaz-Schatz stent. Left is Ziyad Hijazi, M.D., MPH, director of the Sidra Cardiac Program. #SCAI, #SCAI2018

Richard Schatz, M.D., (center) research director of cardiovascular interventions at the Heart, Lung, and Vascular Center at Scripps Clinic, speaking at a 2018 SCAI session on collaboration with industry to bring new device technologies to market. He is best known as the co-inventor of the first coronary stent, the Palmaz-Schatz stent. Left is Ziyad Hijazi, M.D., MPH, director of the Sidra Cardiac Program, Sidra Medical and Research Center, Doha, Qatar, who has been active in new device technologies for structural heart disease.

Here is an aggregation of all the news and late-breaking studies presented at the 2018 Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions. 

 

Late-breaking Studies:

Derivation of a Simple Risk Tool to Predict 30-day Readmissions after Transcatheter Aortic Valve Replacement — Presented by Sahil Khera, M.D., Massachusetts General Hospital

Procedural, Clinical and Health Status Outcomes in Chronic Total Coronary Occlusion Revascularization with Zotarolimus-Eluting Stents: Results from the PERSPECTIVE Trial — Presented by David Kandzari, M.D., Piedmont Heart Institute

Length of Stay Post Trans-Femoral Transcatheter Aortic Valve Replacement — Presented by Siddharth Wayangankar, M.D., Shands/University of Florida

A Prospective, Single-Arm Multicenter Trial of Catheter-Directed Mechanical Thrombectomy for Intermediate-Risk Acute Pulmonary Embolism: The FLARE Study — Presented by Thomas Tu, M.D., Baptist Health Louisville

Immunomodulatory Therapy Reduces Atherosclerotic Plaque Burden by Coronary Computed Tomography Angiography in Psoriasis at One-Year — Presented by Nehal Mehta, M.D., National Heart, Lung, and Blood Institute

Culprit Vessel vs. Multivessel Revascularization Strategies in Acute Myocardial Infarction and Cardiogenic Shock: Insights from the British Columbia Cardiac Registry — Presented by Bilal Iqbal, M.D., Victoria Heart Institute Foundation, Canada

PROGRESS-CTO: The Hybrid Approach of Percutaneous Coronary Interventions for Chronic Total Occlusions — Presented by Peter Tajti, M.D., Abbott Northwestern Hospital

• The Abbott Post-Approval Study 1 MitraClip Registry: 1-year Results of the First 2,000 Patients in the Transcatheter Valve Therapy Registry — Presented by James Hermiller, M.D., The St. Vincent Medical Group at The Heart Center

Strategies to Reduce Acute Kidney Injury and Improve Clinical Outcomes After Percutaneous Coronary Intervention (PCI): A PRESERVE Trial Subgroup Analysis of the Prevention of Serious Adverse Events — Presented by Santiago Garcia, M.D., Minneapolis VA Medical Center

Discrepancy Between Physician Perception and Objective Assessment of Stroke, Stent Thrombosis and Bleeding Risk in Patients with Atrial Fibrillation Undergoing PCI: Results From the Aviator 2 International Registry — Presented by Roxana Mehran, M.D., Icahn School of Medicine at Mount Sinai

 

Other Key Presentations at SCAI:

More Patients Admitted With Cardiac Conditions in Winter Than Other Months

Intravenous Drug Use is Causing Rise in Heart Valve Infections, Healthcare Costs

3-D Printed Models to Guide TAVR Improve Outcomes

SCAI Launches Diagnosis and Treatment Toolkit for Peripheral Artery Disease

Medtronic Shares Two-Year Harmony Transcatheter Pulmonary Valve Results

SCAI Updates Consensus on Length of Stay for Percutaneous Coronary Intervention

SCAI Releases Consensus Guidelines for Femoral-Popliteal Arterial Interventional Device Selection

Follow other SCAI news

 

 

#SCAI2018  #SCAI18  #SCAI

Related Content

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development. #SCAI, #SCAI2018

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development.  

Feature | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin di
Intravenous Drug Use is Causing Rise in Heart Valve Infections, Healthcare Costs. #SCAI, #SCAI2018
News | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 — The opioid drug epidemic is impacting cardiology, with a new study finding the number of patients hosp
Patient Enrollment Completed in U.S. IDE Study of THERMOCOOL SMARTTOUCH SF Catheter
News | Cardiovascular Clinical Studies | March 15, 2018
March 15, 2018 –  Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., who wo
Lexington Begins HeartSentry Clinical Trial
News | Cardiovascular Clinical Studies | February 20, 2018
February 20, 2018 – Lexington Biosciences, Inc., a development-stage medical device company, announced the commenceme
Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study
News | Cardiovascular Clinical Studies | February 06, 2018
February 6, 2018 – Endologix, a developer and marketer of treatments for aortic disorders, announced the completion o
12-Month Results from Veryan Medical's MIMICS-2 IDE Study Presented at LINC
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 – Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s MIMICS
LimFlow Completes U.S. Feasibility Study Enrollment, Receives FDA Device Status
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 –  LimFlow SA, developer of minimally-inv
ESC 2017 late breaking trial hot line study presentations.
News | Cardiovascular Clinical Studies | September 12, 2017
September 12, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking C
U.K., NHS studies, weekend effect, hospital admission, atrial fibrillation, heart failure
News | Cardiovascular Clinical Studies | June 28, 2016
New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom for atrial...
stroke risk
News | Cardiovascular Clinical Studies | August 28, 2015
Most people assume strokes only happen to octogenarians, but recent evidence suggests that survivors of childhood can
Overlay Init